The following biotech stocks touched a new 52-week high yesterday.AVEO Pharmaceuticals Inc. (AVEO) is just one step away from getting a U.S. patent for the use of its lead product Fotivda for the treatment of refractory advanced renal cell carcinoma. Shares touched a 52-week intraday high of $9.62 yesterday. Yesterday, the company announced that the United States Patent and Trademark Office ("USPT...
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.